Amphastar Pharmaceuticals (AMPH) FCF Margin Growth (3y) (2016 - 2026)
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) FCF Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.60 Bn | 38.95 Bn | 2.15 Bn | 213.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -291.00 |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -1,879.00 |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn | -263.00 |
| 5 | Bausch Health Companies | 2.36 Bn | 520.75 Mn | 2.10 Bn | 1,258.00 |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 46,147.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 460.00 |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | -824.00 |
| 9 | Fennec Pharmaceuticals | 411.09 Mn | 369.84 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 181.39 Mn | 181.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -824.00 |
| Mar 31, 2026 | 32.00 |
| Dec 31, 2025 | 683.00 |
| Sep 30, 2025 | 1,234.00 |
| Jun 30, 2025 | 1,644.00 |
| Mar 31, 2025 | -2,230.00 |
| Dec 31, 2024 | -1,886.00 |
| Sep 30, 2024 | 2,829.00 |
| Jun 30, 2024 | 859.00 |
| Mar 31, 2024 | 1,230.00 |
| Dec 31, 2023 | 21.00 |
| Sep 30, 2023 | 2,618.00 |
| Jun 30, 2023 | 910.00 |
| Mar 31, 2023 | 2,978.00 |
| Dec 31, 2022 | 991.00 |
| Sep 30, 2022 | 3,809.00 |
| Jun 30, 2022 | -5,522.00 |
| Mar 31, 2022 | 5,960.00 |
| Dec 31, 2021 | 2,784.00 |
| Sep 30, 2021 | -831.00 |